Calculate total external body surface area in square meters (m²) and square feet (ft²) across standard medical equations (Mosteller, Du Bois, Haycock, Gehan & George, Boyd, and Fujimoto) for oncology dosing, nephrology eGFR normalization, and cardiac indexing.
Synchronized height: 168 cm • 5 ft 6 in.
Body Surface Area scales proportionally with cardiac output, metabolic rate, and renal glomerular filtration rate. For medications with narrow therapeutic windows (such as cytotoxic chemotherapy agents), dosing per mg/m² of BSA drastically reduces systemic toxicity compared to simple weight-based (mg/kg) dosing.
Average Adult Female / eGFR Standard: ~1.73 m². Patient anthropometrics: 65 kg (65 kg) and 168 cm (5′ 6″).
| Equation & Author | BSA (m²) | BSA (ft²) |
|---|---|---|
Mosteller Formula(1987) Universal Clinical & Chemotherapy Standard | 1.74 | 18.75 |
Du Bois & Du Bois(1916) Classic Historical Benchmark (Adults) | 1.74 | 18.71 |
Haycock Formula(1978) Pediatrics, Neonates & Infants | 1.75 | 18.80 |
Gehan & George(1970) Diverse Adult Clinical Cohorts | 1.75 | 18.88 |
Boyd Formula(1935) Logarithmic Exponent Model | 1.76 | 18.90 |
Fujimoto Formula(1968) Asian Anthropometric Cohorts | 1.69 | 18.23 |
How healthcare providers utilize exact BSA calculations across oncology, nephrology, cardiology, and emergency medicine.
Cytotoxic oncology medications exhibit steep dose-response curves with narrow margins between therapeutic efficacy and life-threatening toxicity. BSA accounts for individual metabolic clearance and vascular volume far better than body weight alone.
Glomerular filtration rate is universally indexed to a standard adult BSA of 1.73 m². To calculate a patient's true absolute filtration rate in mL/min, clinicians multiply normalized eGFR by (Patient BSA / 1.73).
Cardiac Output is normalized to body size as the Cardiac Index (CI = CO / BSA). A normal resting cardiac index is 2.6 to 4.2 L/min/m², critical for evaluating cardiogenic shock and heart failure severity.
Burn triage equations (such as the Parkland and Galveston formulas) quantify total body surface area burned (% TBSA) and prescribe intravenous lactated Ringer's fluid volume based directly on BSA in pediatric cases.
Body Surface Area (BSA) quantifies the total two-dimensional surface boundary of the human body. Below is an exhaustive clinical guide exploring metabolic scaling principles, equation derivations, and comparative pharmacology.
Direct measurement of human surface area requires intricate 3D optical body scanning or physical coating techniques. In routine clinical practice, mathematical equations estimate BSA from height and weight.
In comparative physiology, allometric metabolic scaling (Kleiber's Law and Rubner's surface law) demonstrates that basal metabolic heat generation, renal blood flow, hepatic drug clearance, and respiratory gas exchange scale more closely with two-dimensional surface area than with three-dimensional body mass.
Adipose fat tissue is relatively hypovascular and metabolically inert compared to visceral lean muscle mass. Weight-based dosing in obese or underweight patients creates significant peak concentration errors, whereas BSA naturally moderates these extremes.
BMI is a unitless ratio ($kg/m^2$) representing relative heaviness for height. BSA is an actual physical area ($m^2$) representing boundary geometry and functional organ volume capacity.
Answers to common clinical questions regarding formula differences, pediatric adjustments, and dosing safety.